Business

Eli Lilly gets Indian emergency use nod for antibody drug combination

U.S. drugmaker Eli Lilly and Co said on Tuesday its antibody drug combination has received an emergency use approval in India for the treatment of mild to moderate COVID-19 cases.

FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant is pictured in Branchburg, New J
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo

Bookmark

BENGALURU: U.S. drugmaker Eli Lilly and Co said on Tuesday its antibody drug combination has received an emergency use approval in India for the treatment of mild to moderate COVID-19 cases.

(Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V)

Source: Reuters